White JM - Search Results

1

Blocking monoclonal antibodies specific for mouse IFN-alpha/beta receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection.

Sheehan KC, Lai KS, Dunn GP, Bruce AT, Diamond MS, Heutel JD, Dungo-Arthur C, Carrero JA, White JM, Hertzog PJ, Schreiber RD. Sheehan KC, et al. Among authors: white jm. J Interferon Cytokine Res. 2006 Nov;26(11):804-19. doi: 10.1089/jir.2006.26.804. J Interferon Cytokine Res. 2006. PMID: 17115899

2

Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway.

Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, Dighe AS, Kaplan DH, Riley JK, Greenlund AC, Campbell D, Carver-Moore K, DuBois RN, Clark R, Aguet M, Schreiber RD. Meraz MA, et al. Among authors: white jm. Cell. 1996 Feb 9;84(3):431-42. doi: 10.1016/s0092-8674(00)81288-x. Cell. 1996. PMID: 8608597 Free article.

3

Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses.

Rodig SJ, Meraz MA, White JM, Lampe PA, Riley JK, Arthur CD, King KL, Sheehan KC, Yin L, Pennica D, Johnson EM Jr, Schreiber RD. Rodig SJ, et al. Among authors: white jm. Cell. 1998 May 1;93(3):373-83. doi: 10.1016/s0092-8674(00)81166-6. Cell. 1998. PMID: 9590172 Free article.

4

TCR transgenic mice in which usage of transgenic alpha- and beta-chains is highly dependent on the level of selecting ligand.

Kersh GJ, Donermeyer DL, Frederick KE, White JM, Hsu BL, Allen PM. Kersh GJ, et al. Among authors: white jm. J Immunol. 1998 Jul 15;161(2):585-93. J Immunol. 1998. PMID: 9670931

5

Eradication of established tumors by CD8+ T cell adoptive immunotherapy.

Hanson HL, Donermeyer DL, Ikeda H, White JM, Shankaran V, Old LJ, Shiku H, Schreiber RD, Allen PM. Hanson HL, et al. Among authors: white jm. Immunity. 2000 Aug;13(2):265-76. doi: 10.1016/s1074-7613(00)00026-1. Immunity. 2000. PMID: 10981969 Free article.

6

Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice.

Yin L, Wu L, Wesche H, Arthur CD, White JM, Goeddel DV, Schreiber RD. Yin L, et al. Among authors: white jm. Science. 2001 Mar 16;291(5511):2162-5. doi: 10.1126/science.1058453. Science. 2001. PMID: 11251123

7

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity.

Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ, Schreiber RD. Shankaran V, et al. Among authors: white jm. Nature. 2001 Apr 26;410(6832):1107-11. doi: 10.1038/35074122. Nature. 2001. PMID: 11323675

8

A critical function for type I interferons in cancer immunoediting.

Dunn GP, Bruce AT, Sheehan KC, Shankaran V, Uppaluri R, Bui JD, Diamond MS, Koebel CM, Arthur C, White JM, Schreiber RD. Dunn GP, et al. Among authors: white jm. Nat Immunol. 2005 Jul;6(7):722-9. doi: 10.1038/ni1213. Epub 2005 Jun 12. Nat Immunol. 2005. PMID: 15951814

9

Interferon-gamma and cancer immunoediting.

Dunn GP, Ikeda H, Bruce AT, Koebel C, Uppaluri R, Bui J, Chan R, Diamond M, White JM, Sheehan KC, Schreiber RD. Dunn GP, et al. Among authors: white jm. Immunol Res. 2005;32(1-3):231-45. doi: 10.1385/ir:32:1-3:231. Immunol Res. 2005. PMID: 16106075 Review.

10

Type I interferon is selectively required by dendritic cells for immune rejection of tumors.

Diamond MS, Kinder M, Matsushita H, Mashayekhi M, Dunn GP, Archambault JM, Lee H, Arthur CD, White JM, Kalinke U, Murphy KM, Schreiber RD. Diamond MS, et al. Among authors: white jm. J Exp Med. 2011 Sep 26;208(10):1989-2003. doi: 10.1084/jem.20101158. Epub 2011 Sep 19. J Exp Med. 2011. PMID: 21930769 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,296 results

Search Page

Filters